Executive Summary
Acute Lymphocytic Leukemia (ALL) is an uncommon disease accounting for less than 1% of cancers diagnosed in the United States. People from any age group can contradict Acute Lymphocytic Leukemia. However, this disease is most common in children. It is common in children and teenagers, accounting for 74% of leukemia. The general risk of ALL rises after age 50. The count of new ALL cases rose by 1% between 2007 and 2016, and the death rate dropped 1% between 2008 and 2017. The 5-year survival rate is 38% for people of age 20 and older and 89% for people below age 20.
Statistics of Acute lymphocytic Leukemia
Children younger than five have the highest risk of ALL. After the child grows into adulthood, the general risk of ALL rises after age 50. About four out of every ten people diagnosed with ALL are adults.
The count of new ALL cases rose by 1% each year between 2007 and 2016, and the death rate dropped 1% each year between 2008 and 2017 1.
The 5-year survival rate reveals what percent of people live at least five years after the cancer is found. 5-year survival rate is 38% for people aged 20 and older 2. The 5-year survival rate for people below age 20 is about 89%. Recent advances in treatment have remarkably lengthened the lives of people having ALL. However, survival rates depend on various factors, including biological features of the disease and the age.
References
- 1.Yi M, Zhou L, Li A, Luo S, Wu K. Global burden and trend of acute lymphoblastic leukemia from 1990 to 2017. aging. Published online November 16, 2020. doi:10.18632/aging.103982
- 2.Carobolante F, Chiaretti S, Skert C, Bassan R. Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population. Therapeutic Advances in Hematology. Published online January 2020:204062072090353. doi:10.1177/2040620720903531
